South & Central America dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

The South & Central America dPCR and qPCR market was valued at US$ 579.36 million in 2022 and is expected to reach US$ 974.29 million by 2030; it is estimated to grow at a CAGR of 6.7% from 2022 to 2030.

Growing Adoption of PCR Methods in Emerging Countries Drive South & Central America dPCR and qPCR Market

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the South & Central America dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

South & Central America dPCR and qPCR Market Overview

Cancer is one of the significant causes of mortality in Brazil. In the last few years, cancer cases have increased across the country. According to Revista Brasileira de Cancerologia, in 2023, there will be 7.04 million new cases of cancer in Brazil. Further, dPCR and qPCR are major tools for cancer diagnosis, and technological advancements in these tools enhance the diagnosis. Also, the increasing incidence of yellow fever is a public health concern in Brazil. Three countries in the Americas reported confirmed cases of yellow fever in 2022 between epidemiological week (EW) 1 and EW 52: Bolivia (5 confirmed cases), Brazil (5 cases and 4 deaths during the seasonal period of 2021-2022), and Peru (7 confirmed cases, including 5 deaths). dPCR and qPCR methods offer rapid, sensitive, and highly specific detection of the yellow fever virus. Thus, an increase in cancer and yellow fever cases bolster the deployment of dPCR and qPCR solutions across Brazil.

South & Central America dPCR and qPCR Market Segmentation

The South & Central America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the South & Central America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the South & Central America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the South & Central America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the South & Central America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the South & Central America dPCR and qPCR market is segmented into segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America dPCR and qPCR market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America dPCR and qPCR market.